Piramal Enterprises Q3 net profit at Rs 322 crore

Piramal Enterprises today reported a consolidated net profit of Rs 321.71 crore and net sales at Rs 1,847.71 crore for the December quarter.

In a BSE filing, Piramal Enterprises said that "its wholly-owned Critical Care subsidiary in the UK has entered into an agreement to acquire five anesthesia and pain management injectable products from Janssen Pharmaceutica NV. (PTI)

Piramal Enterprises today reported a consolidated net profit of Rs 321.71 crore and net sales at Rs 1,847.71 crore for the December quarter.

The company had posted a net profit of Rs 249.02 crore and net sales of Rs 1,385.12 crore during the same period last fiscal.

The results are not comparable on the account of various acquisitions and divestitures such as stake sale in Vodafone India and lab diagnostics and point-of-care business, Piramal Enterprises said in a regulatory filing.

During the quarter, the revenue from pharmaceuticals manufacturing and services stood at Rs 924.54 crore while income from financial services and information management was Rs 507.59 crore and Rs 426.60 crore, respectively.

Piramal Enterprises’ was trading 1.79 per cent down at Rs 954.55 on BSE during the afternoon session.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express Telegram Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.